DRUG - search results

During “Advances in vaccines”, a health conference held in Spain, professionals of the medical industry brought out the importance of 3D printing for advancing the efficiency of administering as well as customizing vaccines. The Association...

Life-saving drugs for rare disease patients Aprecia Pharmaceuticals and Cycle Pharmaceuticals will collaborate to develop commercialize orphan drugs manufactured using 3D printing technology. Both companies are pharmaceutical industries. Aprecia is a 3D printing pharmaceutical company...

This FDA clearance enables 3D Systems to significantly expand its PEEK product portfolio through the EXT 220 MED platform. The Food and Drug Administration (FDA) has provided 510(k) clearance for 3D Systems’ 3D-printed, patient-specific...

Described as a first-to-market, 3D Systems’ new solution for jetted, monolithic (one-piece) dentures utilizes multiple materials to deliver a “durable, long-wear, aesthetically beautiful prosthetic” to the patient. Thanks to a formulation of tailor-made materials for both...

When they say, 3D printing can help create “anything”, this might actually be true. We have witnessed the possibility of 3D printing to process all types of materials from wood, to glass but this...

Building on traction in UK and Europe, Carcinotech plans expansion in the US In the list of all vertical industries adopting AM technologies, our recap of the year 2023 revealed that the medical and healthcare...

Before starting this “2023 year in review” article, I had a look at what I wrote last year: consolidation through acquisitions & funding dominated the market, materials & software called the tune in the...

Ricoh USA, Inc. is partnering with Materialise to provide patient-specific software solutions for 3D printed medical models used in the healthcare industry.   The company announced this partnership to bolster RICOH 3D for Healthcare at the...

Oxford University researchers have made a breakthrough which opens the door to 3D printing technology usage in brain injury treatments. Scientists have developed a way to deploy neural cells as 3D-printed parts to mimic...

Humonix Biosciences, Inc., a specialty pharmaceutical research company, has developed a new 3D human tissue model, called the retinal vascular dysfunction model. Humonix’s new model is a physiologically relevant 3D model of the blood-retinal barrier....